Scholars Central

Conference abstract

ESKAPE active antibiotics avoiding resistance development

Authors: Brice Felden

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Infections caused by bacteria with developed resistance to nearly all antibiotic classes are critically spreading. They represent a major cause of mortality and morbidity worldwide, and urgently require new compounds into clinical practice. Here we present cyclic pseudomimetic antibiotics bactericidal against ESKAPE human multi-resistant clinical isolates and stable in human sera. Modified, unnatural amino acids are required for stability and antibacterial activity on infected mice. These novel antibiotics trigger bacterial deformity, induce cell wall dissolution and alter membrane permeability. Two are active against methicillin- and vancomycin resistant Staphylococcus aureus on a mice sepsis model and also on a skin infection model. Upon prolonged exposure to the antibiotics in vitro and in infected mice, multiresistant S. aureus did not develop resistance. Three-dimensional structures of the lead compound with and without modified amino-acids provide structural insights on its activity.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Infectious Diseases and Treatment.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases and Treatment
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Brice Felden”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels